Drug News

Preferred Medical continues to serve you by staying up to date on industry changes and drug updates that impact you. Download the reports below to learn more.

Drug Update: LYRICA

Pfizer’s patent on LYRICA, an anti-epileptic drug used to treat fibromyalgia or nerve pain, has been extended until June 30, 2019. For Preferred Medical, LYRICA is number eight in utilization and number one in cost. One reason for LYRICA’s high usage is the search for an alternative to opioids to treat chronic pain. Any claims currently …
Read More